"Receptor, ErbB-4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell surface protein-tyrosine kinase receptor that has specificity for EPIREGULIN; BETACELLIN; NEUREGULINS; and HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR.
| Descriptor ID |
D066247
|
| MeSH Number(s) |
D08.811.913.696.620.682.725.400.009.600 D12.776.543.750.630.009.600 D12.776.543.750.750.400.074.600 D12.776.624.664.700.791 D23.101.140.760
|
| Concept/Terms |
Receptor, ErbB-4- Receptor, ErbB-4
- c-ErbB-4 Protein
- c ErbB 4 Protein
- Receptor Protein-tyrosine Kinase ErbB-4
- Receptor Protein tyrosine Kinase ErbB 4
- HER-4 Proto-oncogene Protein
- HER 4 Proto oncogene Protein
- Protein, HER-4 Proto-oncogene
- Proto-oncogene Protein, HER-4
- Proto-oncogene Protein HER-4
- HER-4, Proto-oncogene Protein
- Protein HER-4, Proto-oncogene
- Proto oncogene Protein HER 4
- v-erb-a Erythroblastic Leukemia Viral Oncogene Homolog 4 (avian) Protein
- Receptor Tyrosine-protein Kinase ErbB-4
- Receptor Tyrosine protein Kinase ErbB 4
- ErbB-4 Receptor
- ErbB 4 Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptor, ErbB-4".
- Chemicals and Drugs [D]
- Enzymes and Coenzymes [D08]
- Enzymes [D08.811]
- Transferases [D08.811.913]
- Phosphotransferases [D08.811.913.696]
- Phosphotransferases (Alcohol Group Acceptor) [D08.811.913.696.620]
- Protein Kinases [D08.811.913.696.620.682]
- Protein-Tyrosine Kinases [D08.811.913.696.620.682.725]
- Receptor Protein-Tyrosine Kinases [D08.811.913.696.620.682.725.400]
- ErbB Receptors [D08.811.913.696.620.682.725.400.009]
- Receptor, ErbB-4 [D08.811.913.696.620.682.725.400.009.600]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptor Protein-Tyrosine Kinases [D12.776.543.750.630]
- ErbB Receptors [D12.776.543.750.630.009]
- Receptor, ErbB-4 [D12.776.543.750.630.009.600]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Growth Factor [D12.776.543.750.750.400]
- ErbB Receptors [D12.776.543.750.750.400.074]
- Receptor, ErbB-4 [D12.776.543.750.750.400.074.600]
- Neoplasm Proteins [D12.776.624]
- Oncogene Proteins [D12.776.624.664]
- Proto-Oncogene Proteins [D12.776.624.664.700]
- Receptor, ErbB-4 [D12.776.624.664.700.791]
- Biological Factors [D23]
- Biomarkers [D23.101]
- Biomarkers, Tumor [D23.101.140]
- Receptor, ErbB-4 [D23.101.140.760]
Below are MeSH descriptors whose meaning is more specific than "Receptor, ErbB-4".
This graph shows the total number of publications written about "Receptor, ErbB-4" by people in this website by year, and whether "Receptor, ErbB-4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptor, ErbB-4" by people in Profiles.
-
The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease. ACS Infect Dis. 2021 06 11; 7(6):1483-1502.
-
The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib. Cancer Biol Ther. 2018 02 01; 19(2):132-137.
-
Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis. Lung Cancer. 2017 10; 112:47-56.
-
Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. Cell Cycle. 2015; 14(4):648-55.
-
Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma. Cancer. 2012 Oct 15; 118(20):5140-54.
-
Association of common variants in ERBB4 with congenital left ventricular outflow tract obstruction defects. Birth Defects Res A Clin Mol Teratol. 2011 Mar; 91(3):162-8.
-
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer. J Urol. 2008 Jan; 179(1):353-8.
-
Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. J Biol Chem. 2003 Aug 15; 278(33):30748-54.
-
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res. 1999 Dec; 5(12):4164-74.
-
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. Clin Cancer Res. 1999 Nov; 5(11):3653-60.